Skip to main content

Epigenetics in Human Disease

Submitted by SEA-EU_UALG on

Research Areas & Expertise

MEDICAL AND HEALTH SCIENCES

Principal Investigator

Pedro Castelo Branco

castelobranco.pedro@gmail.com

Faculty/school/department
Faculty of Medicine and Biomedical Sciences, University of Algarve, Portugal
Composition of Joint Unit of Research

Pi, Phd and Master Students.

PI name
Pedro Castelo Branco
Short description of research profile

The overall objectives of the Epigenetics and Human Disease Laboratory are to analyze epigenetic signatures and explore their potential role in aging, multiorgan dysfunction syndromes and cancer development, adding diagnostic and prognostic value in order to help designing therapeutic approaches in an era of personalized medicine. The work is primarily focused on human cancer and sepsis with emphasis on basic research on human tissue and cells with a strong clinical association.

Contact person
Pedro Castelo Branco
Contact person e-mail

Chloe Gui, Justin Z Wang, Vikas Patil, Alexander P Landry, Olivia Singh, Pedro Castelo-Branco, Uri Tabori, Kenneth Aldape, Felix Behling, Jill S Barnholtz-Sloan, Craig Horbinski, Ghazaleh Tabatabai, Andrew Ajisebutu, Jeff Liu, Zeel Patel, Rebeca Yakubov, Ramneet Kaloti, Yosef Ellenbogen, Christopher Wilson, Aaron Cohen-Gadol,…Prof Gelareh Zadeh.  Analysis of TERT association with clinical outcome in meningiomas: a multi-institutional cohort study (2025). DOI: 10.1016/S1470-2045(25)00267-0 Lancet Oncology (Q1; IF 35,9; Cit=1)

https://drive.google.com/file/d/1n3Rg_WPqNCPKouBsW1ewZmloC749Efwr/view?usp=sharing 

Cândida Cardoso, Daniel Pestana, Sreemol Gokuladhas, Ana D Marreiros, Justin M O'Sullivan, Alexandra Binnie, Mónica T Fernandes and Pedro Castelo-Branco. Identification of Novel DNA Methylation Prognostic Biomarkers for AML With Normal Cytogenetics (2024). https://doi.org/10.1200/CCI.23.00265 JCO Clinical Cancer Informatics (Q1; IF 3,3; Cit=1)

https://drive.google.com/file/d/1kf1VDUjR5Z7kOSeFePZFqCopdeJXk8H_/view?usp=sharing

Joana Dias Apolónio, João S Dias, Mónica Teotónio Fernandes, Martin Komosa, Tatiana Lipman, Cindy H Zhang, Ricardo Leão, Donghyun Lee, Nuno Miguel Nunes, Ana-Teresa Maia, José L Morera, Luis Vicioso, Uri Tabori and Pedro Castelo-Branco. THOR is a targetable epigenetic biomarker with clinical implications in breast cancer (2022). 14:178; https://doi.org/10.1186/s13148-022-01396-3. Clinical Epigenetics (Q1; IF 4,8; Cit=11)

https://drive.google.com/file/d/17GeWBQpXlGTdBMQeUMGApyhclk_T_4DD/view?usp=sharing

Inês Faleiro, Vânia Palma Roberto, Secil Demirkol Canli, Nicolas A Fraunhoffer, Juan Iovanna, Ali Osmay Gure, Wolfgang Link and Pedro Castelo-Branco. DNA methylation of PI3K/AKT pathway-related genes predicts outcome in patients with pancreatic cancer: a comprehensive bioinformatics-based study. (2021). 13(24), 6354; https://doi.org/10.3390/cancers13246354. Cancers (Q1; IF 4,5; Cit=7)

https://drive.google.com/file/d/1OI7ZwH_HYY8ypSqSNGALo-agcKysW8Ua/view?usp=sharing

Size of the team
from 4 to 7
number of PhD students
7
Size of the team